Albumin-to-D-dimer Ratio and Long-Term Outcomes for 2,675 STEMI Patients

2,675 patient records from a retrospective cohort study of ST-elevation myocardial infarction survivors admitted between January 2014 and December 2021. Guangze Xiang published this data on figshare in 2026, showing a mean follow-up period of 1,013 days. The analysis links low Albumin-to-D-dimer ratio levels to higher rates of all-cause mortality and new-onset stroke after hospital discharge.

Use Cases

• Predicting all-cause mortality risk based on Albumin-to-D-dimer ratio levels.
• Assessing the likelihood of new-onset stroke in STEMI survivors using inflammatory marker data.
• Training models for risk stratification of major adverse cardiovascular events (MACE) after hospital discharge.
• Validating the Albumin-to-D-dimer ratio as a prognostic biomarker in retrospective cohort studies.

Strengths

• Data covers 2,675 patients, providing a substantial cohort size.
• Follow-up period is detailed with a mean of 1,013 days and an interquartile range.
• Specific hazard ratios and confidence intervals for outcomes are provided in the description.
• Released under a CC-BY-4.0 license, allowing for open reuse and modification.

Limitations

• Row count and column-level documentation for the dataset file are unknown.
• Data is from a single hospital, which may limit generalizability.
• The 9.7 KB file size suggests a limited scope, likely containing summary or processed results rather than raw patient-level data.

Provenance

Source

figshare, authored by Guangze Xiang.

Collection Method

Retrospective analysis of hospital admission data.

Time Range

Patient admissions from January 2014 to December 2021, with follow-up.

Freshness

Last updated 2026-03-18 07:39:04.

Geography

Hospital location is not specified in the provided metadata.